Germany Plans To Buy 31.8M Doses Of Moderna, 18.3M Doses Of Johnson & Johnson, 70M Protein/De-Activated Virus Vaccine Doses For 2022
-Reuters Citing Health Ministry Document
Why Moderna Shares Are Moving Today
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 1.3% at $237.50 on continued strength after the company on Tuesday announced data showing its COVID-19 vaccine produced neutralizing titers against multiple COVID-19 variants.
Stocks That Hit 52-Week Highs On Wednesday
This morning 132 companies reached new 52-week highs.
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 29)
Moderna COVID-19 Vaccine Authorized For Emergency Use In India: What You Need To Know
Moderna, Inc.'s (NASDAQ: MRNA) COVID-19 vaccine should soon find its way into India, one of the countries worst affected by the second
Moderna’s COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested
Moderna Inc (NASDAQ:MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine.…
Stocks That Hit 52-Week Highs On Tuesday
Tuesday's morning session saw 105 companies set new 52-week highs.
UPDATE: Moderna Says ‘Vaccination with the Moderna COVID-19 Vaccine produced neutralizing titers against all variants tested’ Including Beta, Kappa, Eta And Delta Variant
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new results from in vitro neutralization studies of sera from individuals vaccinated
Moderna Provides Clinical Update On Neutralizing Activity OfCOVID-19 Vaccine On Emerging Variants Including Delta Variant
Serum samples from eight participants obtained one week after second dose of the primary series in the Phase 1 clinical trial of the Moderna COVID-19 Vaccine
Serum neutralization assays performed on emerging variants
Moderna Hires Ogilvy Health CEO Kate Cronin As Chief Brand Officer To Build On COVID-19 Vaccine Momentum
COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA) announced Monday a new hire to enhance its brand appeal.